It was reported that apelin regulates insulin sensitivity, stimulates glucose utilization and enhances brown adipogenesis in different tissues associated with diabetes 12, 41, indicating the apelin–APJ system as a novel therapeutic target for pharmacological intervention in treating diabetes. Here, APLN is linked to diabetes mellitus.